JasiaMahdiMD

Summary

• Dr. Jasia Mahdi is a child neurologist and pediatric neuro-oncologist based in Houston, TX. In 2022, she concluded her fellowships in Pediatric Neuro-Oncology and Neuro-Immuno-Oncology at Stanford University after her residencies in Child Neurology and Pediatrics at the Washington University/B-JH/SLCH Consortium, which followed her graduation from Vanderbilt University School of Medicine in 2015. Dr. Mahdi was then a Clinical Instructor at Lucile Packard Children's Hospital Stanford where she served as the Co-PI of a phase I clinical trial utilizing GD2 CAR T therapy for the treatment of H3K27M-mutated diffuse midline gliomas. Currently, she is an Assistant Professor of Neuro-Oncology and Director of Neuro-Oncology for the Division of Pediatric Neurology at Texas Children’s Hospital/Baylor College of Medicine. Her publication record demonstrates a strong focus on pediatric neuro-oncology, with pieces receiving multiple citations in Nature Medicine, Stroke, Nature, and Neurology—including highly cited research on GD2-CAR T cell therapy.